Whole Health at Risk: Does EU Joint Clinical Assessment Conflict with Europe’s Antimicrobial Resistance Ambitions?

Name: Whole Health at Risk: Does EU Joint Clinical Assessment Conflict with Europe’s Antimicrobial Resistance Ambitions?
Start: 2026-11-09T16:45
End: 2026-11-09T17:45
Location: Austria Center Vienna

ISPOR Europe 2026 · 9 November 2026 · 16:45–17:45

Whole Health at Risk: Does EU Joint Clinical Assessment Conflict with Europe’s Antimicrobial Resistance Ambitions? was a session at ISPOR Europe 2026 on 9 November 2026 in Vienna, with 4 speakers on record.

Speakers

Libby Hamson — Speaker Global Pricing and Market Access Director, GSK
Matthias Hofer — Moderator Principal Economist, Office of Health Economics
Patrick K Hopkinson — Speaker Independent Consultant
Anja E Schiel — Speaker Norwegian Medicines Agency